Ga. Comp. R. & Regs. R. 480-34-.11 - Levocetirizine Dihydrochloride

(1) This rule was adopted to protect the health, safety, and welfare of the public. Levocetirizine dihydrochloride in 5 mg tablets or an oral solution of 2.5 mg per 5 mL (.05 mg per mL), as identified in Official Code of Georgia Annotated (O.C.G.A.) § 16-13-71(b)(516.75), is hereby removed from the list of dangerous drugs of the Georgia Dangerous Drugs Act.
(2) This rule is based on the following findings of the Board:
(a) that levocetirizine dihydrochloride does not have a high potential for abuse;
(b) that the Board has considered the scientific evidence of its pharmacological effects; the state of current scientific knowledge regarding the drug; the history and current pattern of abuse; the scope, duration, and significance of abuse; the potential of the drug to produce psychic or physiological dependence liability; and
(c) that the drug, when in 5 mg tablets or an oral solution of 2.5 mg per 5 mL (.05 mg per mL), has been approved for non-prescription status by the Federal Food and Drug Administration.


Ga. Comp. R. & Regs. R. 480-34-.11
O.C.G.A. §§ 16-13-71, 26-4-27.
Original Rule entitled "Levocetirizine Dihydrochloride" adopted. F. Oct. 3, 2017; eff. Oct. 23, 2017.

State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.

No prior version found.